Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 128.99%248.74M | 393.02%85.95M | 244.08%80.57M | 29.24%63.16M | 0.84%19.06M | 2.07%108.62M | 17.43M | 23.42M | 48.87M | 18.91M |
Operating revenue | 126.91%226.55M | 636.85%63.76M | 283.24%94.5M | 3.35%49.22M | 0.84%19.06M | -4.53%99.84M | --8.65M | --24.66M | --47.62M | --18.91M |
Cost of revenue | 107.54%124.23M | 79.29%33.73M | 109.19%33.1M | 132.70%30.42M | 122.05%26.98M | 20.83%59.86M | 18.81M | 15.82M | 13.07M | 12.15M |
Gross profit | 155.33%124.51M | 3,884.13%52.22M | 525.17%47.47M | -8.55%32.74M | -217.19%-7.92M | -14.28%48.76M | -1.38M | 7.59M | 35.8M | 6.76M |
Operating expense | 106.91%55.07M | 122.46%14.62M | 105.81%14.27M | 66.40%14.01M | 159.36%12.18M | 69.56%26.61M | 6.57M | 6.93M | 8.42M | 4.7M |
Selling and administrative expenses | 105.46%51.56M | 93.29%9.76M | 114.49%14.87M | 67.91%14.13M | 172.57%12.8M | 80.79%25.09M | --5.05M | --6.93M | --8.42M | --4.7M |
-Selling and marketing expense | 113.12%1.28M | ---- | ---- | ---- | ---- | -23.60%602K | ---- | ---- | ---- | ---- |
-General and administrative expense | 105.28%50.28M | 90.60%8.48M | 114.49%14.87M | 67.91%14.13M | 172.57%12.8M | 87.08%24.49M | --4.45M | --6.93M | --8.42M | --4.7M |
Depreciation amortization depletion | 372.28%2.52M | ---- | ---- | ---- | ---- | -47.65%534K | ---- | ---- | ---- | ---- |
-Depreciation and amortization | 372.28%2.52M | ---- | ---- | ---- | ---- | -47.65%534K | ---- | ---- | ---- | ---- |
Other operating expenses | -0.10%985K | --2.33M | ---601K | ---127K | ---620K | 23.87%986K | ---- | ---- | ---- | ---- |
Operating profit | 213.52%69.44M | 572.93%37.6M | 4,915.71%33.2M | -31.59%18.73M | -1,075.39%-20.09M | -46.23%22.15M | -7.95M | 662K | 27.38M | 2.06M |
Net non-operating interest income expense | 69.26%-584K | 191.59%1.83M | -9,605.77%-5.05M | 1,164.89%3.31M | -508.04%-681K | -18.53%-1.9M | -2M | -52K | 262K | -112K |
Non-operating interest income | 130.03%3.29M | -76.35%167K | -708.77%-1.74M | 946.01%4.46M | 2,606.67%406K | 486.89%1.43M | --706K | --285K | --426K | --15K |
Non-operating interest expense | -2.78%2.8M | -222.11%-2.75M | 882.79%3.31M | 596.34%1.14M | 755.91%1.09M | 88.10%2.88M | --2.25M | --337K | --164K | --127K |
Total other finance cost | 137.28%1.08M | ---- | ---- | ---- | ---- | 43.40%456K | ---- | ---- | ---- | ---- |
Other net income (expense) | 84.20%-1.38M | -116.26%-8.75M | ||||||||
Gain on sale of security | -32.34%-1.38M | ---- | ---- | ---- | ---- | 74.18%-1.05M | ---- | ---- | ---- | ---- |
Special income (charges) | --0 | ---- | ---- | ---- | ---- | ---7.71M | ---- | ---- | ---- | ---- |
-Less:Restructuring and merger&acquisition | --0 | ---- | ---- | ---- | ---- | --7.71M | ---- | ---- | ---- | ---- |
Income before tax | 486.86%67.48M | 303.47%38.05M | 4,515.90%28.16M | -20.25%22.04M | -1,166.43%-20.77M | -67.65%11.5M | -18.7M | 610K | 27.64M | 1.95M |
Income tax | 2.41M | 797K | 494K | 1.1M | 19K | 0 | 0 | 0 | 0 | 0 |
Net income | 465.92%65.07M | 299.20%37.25M | 4,434.92%27.66M | -24.22%20.95M | -1,167.40%-20.79M | -67.65%11.5M | -18.7M | 610K | 27.64M | 1.95M |
Net income continuous Operations | 465.92%65.07M | 299.20%37.25M | 4,434.92%27.66M | -24.22%20.95M | -1,167.40%-20.79M | -67.65%11.5M | ---18.7M | --610K | --27.64M | --1.95M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 465.92%65.07M | 299.20%37.25M | 4,434.92%27.66M | -24.22%20.95M | -1,167.40%-20.79M | -67.65%11.5M | -18.7M | 610K | 27.64M | 1.95M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 465.92%65.07M | 299.20%37.25M | 4,434.92%27.66M | -24.22%20.95M | -1,167.40%-20.79M | -67.65%11.5M | -18.7M | 610K | 27.64M | 1.95M |
Basic earnings per share | 216.67%0.76 | 283.17%0.44 | 2,476.98%0.3182 | -56.82%0.2418 | -700.00%-0.24 | -72.73%0.24 | -0.2402 | 0.0123 | 0.56 | 0.04 |
Diluted earnings per share | 216.67%0.76 | 283.17%0.44 | 2,476.98%0.3182 | -56.82%0.2418 | -700.00%-0.24 | -72.73%0.24 | -0.2402 | 0.0123 | 0.56 | 0.04 |
Dividend per share | ||||||||||
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |